A Mobile Application, Oncpatient, to Assist Patients Undergoing Radiation Therapy

Malignant Solid Neoplasm Clinical Trial

Official title:

Pilot Study of Mobile Application Designed to Assist Patients Undergoing Radiation Therapy

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT05173961
• Other study ID #: 21564
• Secondary ID: NCI-2021-1383521
• Status: Active, not recruiting
• Phase: N/A
• Start date: June 29, 2022
• Est. completion date: December 22, 2024

Study information

• Verified date: May 2024
• Source: City of Hope Medical Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This clinical trial determines how well the oncpatient mobile application work in assisting patients undergoing radiation treatment. Radiation therapy can be complex. The technology, daily treatments, and possible side effects can be confusing to prevent and manage. Traditional radiation patient education includes a large amount of information, including details of treatment logistics, side effect prevention, and management. However, this information is not always readily accessible or memorable through the long course of therapy, and critical details can be missed. Oncpatient is a mobile application intended to be a more convenient and accessible form of patient education and guidance that is readily available to help patients and their caretakers navigate through radiation treatment.

Description:

PRIMARY OBJECTIVE:

I. To determine the feasibility of implementing a mobile application designed to be an educational resource designed for patients undergoing radiation treatment.

SECONDARY OBJECTIVES:

I. To assess patient opinions on the usability and helpfulness of the mobile application in helping them through radiation treatments.

II. To assess satisfaction with the mobile application and radiation treatment. III. To assess opinions on existing or new features for the mobile application to be given to future patients.

OUTLINE:

Patients use the oncpatient mobile application over the course of radiation therapy. Patients also complete a survey on the final day of radiation treatment.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 20
• Est. completion date: December 22, 2024
• Est. primary completion date: December 22, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Age 18 and older.

• Can read and speak English and provide informed consent.

• Diagnosed with cancer, any stage, any disease site.

• Must be consented to undergo a course of radiotherapy, starting within one month. No limits on duration of radiation apply. Patients must be consented prior to initiating radiotherapy, however.

• Has regular access to a mobile device.

• Note: This requirement unfortunately leads to the exclusion of underserved patients who cannot afford to have a mobile device. Given that the goal of this study is to establish feasibility of a mobile application, there are no true alternatives, given that these patients would require access to a mobile device if this app were commercially available. However, for impacted patients, the relevant application and resources will be made available on iPads they can access during treatment and a website they can access on any web-enabled device, to ensure they have access as much as reasonably possible. Future iterations of the application will aim to increase access to the resource however possible, but limitations will always apply due to how the core functionality of the app requires a mobile device.

Exclusion Criteria:

• Less than 18 years old.

• Non-English speaking.

• Inability to operate a mobile device.

Related Conditions & MeSH terms

• Hematopoietic and Lymphoid Cell Neoplasm
• Malignant Solid Neoplasm
• Neoplasms

Intervention

Other:
• Internet-Based Intervention
Use oncpatient mobile application
• Survey Administration
Complete survey

Locations

Country	Name	City	State
United States	City of Hope Medical Center	Duarte	California

Sponsors (2)

Lead Sponsor	Collaborator
City of Hope Medical Center	National Cancer Institute (NCI)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Completion rate	The percent of patients who indicate in the survey that they were able to download the application and use it at least once during radiation will be defined as the completion rate.	Up to 1 year
Secondary	Patient opinions on the usability and helpfulness of the mobile application in helping them through radiation treatments	Survey responses and collected demographic data will be evaluated with descriptive statistics where possible. Free-text responses will be recorded and utilized by the application developers to inform future iterations of the application.	Up to 1 year
Secondary	Satisfaction with the mobile application and radiation treatment	Survey responses and collected demographic data will be evaluated with descriptive statistics where possible. Free-text responses will be recorded and utilized by the application developers to inform future iterations of the application.	Up to 1 year
Secondary	Opinions on existing or new features for the mobile application to be given to future patients	Survey responses and collected demographic data will be evaluated with descriptive statistics where possible. Free-text responses will be recorded and utilized by the application developers to inform future iterations of the application.	Up to 1 year